State-of-the-art imaging in oesophago-gastric cancer

Br J Radiol. 2022 Sep 1;95(1137):20220410. doi: 10.1259/bjr.20220410. Epub 2022 Jun 15.

Abstract

Radiological investigations are essential in the management of oesophageal and gastro-oesophageal junction cancers. The current multimodal combination of CT, 18F-fluorodeoxyglucose positron emission tomography combined with CT (PET/CT) and endoscopic ultrasound (EUS) has limitations, which hinders the prognostic and predictive information that can be used to guide optimum treatment decisions. Therefore, the development of improved imaging techniques is vital to improve patient management. This review describes the current evidence for state-of-the-art imaging techniques in oesophago-gastric cancer including high resolution MRI, diffusion-weighted MRI, dynamic contrast-enhanced MRI, whole-body MRI, perfusion CT, novel PET tracers, and integrated PET/MRI. These novel imaging techniques may help clinicians improve the diagnosis, staging, treatment planning, and response assessment of oesophago-gastric cancer.

Publication types

  • Review

MeSH terms

  • Esophageal Neoplasms* / diagnostic imaging
  • Esophageal Neoplasms* / pathology
  • Fluorodeoxyglucose F18
  • Humans
  • Magnetic Resonance Imaging
  • Neoplasm Staging
  • Positron Emission Tomography Computed Tomography / methods
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals
  • Stomach Neoplasms* / diagnostic imaging
  • Stomach Neoplasms* / pathology

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18